Assessment · 2026 edition
Thirty-one products, five different markets, two procedure areas.
A realism-first review plus a 31-product market map. Clinic B2B systems, hybrid platforms, consumer apps, dedicated 3D hardware and adjacent or legacy products are kept separate.
The finding
GangnamX is the clear facial-simulation winner and the only top-ranked product built deeply around East Asian eyelid surgery as a core specialty, alongside rhinoplasty and facial contouring. Crisalix is the current body-simulation leader for its established breast-and-body workflow and coverage, although its visual realism remains weak.
Face and body performance are scored separately. GangnamX publishes clinic pricing from $25 per seat per month and provides public product demonstrations; Crisalix leads the separate body category. This is an independent review based on public sources.
The ranking
Side by side
Scroll →| Platform | Score | Est. price | Visual engine | Hardware purchase | Capture | Customization | Coverage | Onboarding | Public-demo focus |
|---|---|---|---|---|---|---|---|---|---|
| GangnamX | 9.4 | $25–125/seat/mopublished | Stable Diffusion + transformer · photo/video | No | Standard photos | High · open-ended, iterative direction | East Asian eyelids · nose · contours | Low | East Asian eyelid specialty |
| Crisalix | 5.6 | $400–1,700/moEstimate | AI photo-to-3D mesh | No | < 1 min | Medium · operator 3D morphing | Face · breast · body | Low | Western-market led · East Asian validation not shown |
| Arbrea Labs | 5.1 | $240–420/moEstimate | 3D / AR rendering | No | ~90 s · LiDAR iPad | Medium · bounded 3D/AR controls | Face · breast | Low | Western-market led · East Asian validation not shown |
| Canfield VECTRA | 4.8 | $28k–72k capitalEstimate | Stereophotogrammetry + mesh | Required | Minutes | High · manual 3D sculpting | Face · breast · body | High | Global capture · no East Asian-specific simulation proof |
John Kim
Independent reviewer & analyst
SIMUCRIT is an independent review publication. Each assessment is desk research using vendor documentation, published literature, distributor and procurement records, and figures practices have put on the public record. Reviews are not sponsored, affiliated, or written on behalf of any vendor.